Company intelligence / Profile preview

Hemerus Medical

Saint Paul, Minnesota, United Stateshemerus.com ↗

Ownership: Private
Development stage: Other

Overview

Hemerus developed advanced technologies to improve the shelf life and quality of blood products. Their SOLX System extends red cell storage up to 42 days. The company was acquired by Haemonetics; some new product launches are pending.

Therapeutic areas: Hematology
Modalities: Device (blood collection and storage systems)Biologic (additive solutions for blood products)
Industry: Biotech

Drug pipeline

3 assets

SOLX

2 more assets in the full pipeline.

Request access →

Partnerships

Not specified; now part of Haemonetics' portfolio.

Beyond the preview

Go deeper on Hemerus Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemerus Medical.

Explore the full profile